Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,242 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07354945Recruiting
Study of myopia control lenses in children
This study tests how well children adapt to special myopia control lenses. It aims to see if these lenses are comfortable and easy to wear for kids with nearsightedness.
Shanghai, Shanghai MunicipalityAges 6–12 - NCT07357610RecruitingPhase 1
Drug interaction study of SIM0270 in healthy adults
This trial tests how SIM0270 interacts with other drugs (itraconazole, rifampin, midazolam) in healthy Chinese adults. It helps doctors understand if SIM0270 is safe and how it works in the body.
Jinan, ShandongAges 18–55 - NCT07355400Recruiting
NeoPill device for reducing mouth bacteria in braces patients
This trial tests a device called NeoPill to reduce bacteria in the mouths of people with braces. It involves a single visit and may help control oral bacteria levels.
LimassolAges 18 years+ - NCT07354724RecruitingPhase 1
Study of DNL952 for adults with late-onset Pompe disease
This trial tests a new drug, DNL952, in adults with late-onset Pompe disease. It aims to see if the drug is safe and how it works in the body, with different groups for people currently on enzyme replacement therapy or those who haven't had it in the past year.
Irvine, CaliforniaAges 18–75 - NCT07361497RecruitingPhase 3
New Drug vs Standard Drug After Chemoradiation for Stage 3 Lung Cancer
This study tests a new drug, pumitamig, against an older drug, durvalumab, for people with stage 3 non-small cell lung cancer that cannot be removed by surgery and has not progressed after chemotherapy and radiation. The goal is to see which drug works better to keep the cancer from growing.
Daphne, AlabamaAges 18 years+ - NCT07361276Recruiting
Observational study on high blood pressure treatment in public clinics
This study looks at how doctors treat high blood pressure in public health clinics. By reviewing medical records, researchers hope to understand what treatments are used and how well they work.
FlorianópolisAges 18 years+ - NCT07361510RecruitingPhase 3
Pumitamig vs Keytruda for advanced lung cancer with high PD-L1
This trial compares an experimental drug called Pumitamig with the approved immunotherapy drug Pembrolizumab (Keytruda) as the first treatment for advanced lung cancer that has high PD-L1 levels. The goal is to see which drug works better and has fewer side effects.
Daphne, AlabamaAges 18 years+ - NCT07356531Recruiting
Thermosensitive Embolic Agent for Liver Cancer TACE
This trial tests a new heat-sensitive embolic agent used during TACE (a procedure that blocks blood flow to tumors and delivers chemotherapy directly to the liver) for primary liver cancer. It aims to see if the agent is safe and effective for patients who need TACE treatment.
Hefei, AnhuiAges 18–80 - NCT07357051RecruitingPhase 3
Flu treatment study for children ages 2 to 12
This trial tests a new oral medicine (JKN2301) for children with the flu. It aims to see if the medicine is safe and works well to treat flu symptoms like fever and cough.
Guangzhou, GuangdongAges 2–11 - NCT07359066RecruitingPhase 1/Phase 2
SPR1020 for advanced solid tumors with DNA repair defects
This trial tests an experimental drug (SPR1020) for people with advanced solid tumors that have not responded to standard treatments, especially those with BRCA or related gene mutations. The drug is taken by mouth and the study aims to find the right dose and see if it helps shrink tumors.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07358377RecruitingPhase 1
Combination therapy for HR-positive, HER2-negative cancer
This trial tests a new drug, HRS-6209, combined with other treatments for people with hormone receptor-positive, HER2-negative cancer. The goal is to see if the combination is safe and works well.
Bowral, New South WalesAges 18 years+ - NCT07357285Recruiting
Stroke treatment trial for smaller vessel blockages
This trial tests a new catheter device to remove blood clots from smaller brain arteries in people having a stroke. It aims to see if the device is safe and effective for patients treated within 24 hours of symptoms starting.
BonnAges 18 years+ - NCT07355270Recruiting
Radiofrequency vapor ablation for type 2 diabetes
This trial tests a new device that uses radiofrequency energy to treat the lining of the upper small intestine in people with type 2 diabetes. The goal is to see if this treatment is safe and helps improve blood sugar control.
Scottsdale, ArizonaAges 22–65 - NCT07358650Recruiting
MIST device for lowering eye pressure in glaucoma
This study tests a new device called MIST that is placed inside the eye to help lower eye pressure in people with primary open-angle glaucoma. It may be an option for those whose pressure is still too high despite using eye drops.
Dieppe, New BrunswickAges 40 years+ - NCT07355543Recruiting
Freezing device for skin tags: test of a new pen
This trial tests a new cryogenic pen that freezes off skin tags to see if it works better than an existing device. It may be an option if you have small, soft, skin-colored skin tags in certain body areas.
VilleurbanneAges 22 years+ - NCT07354841Recruiting
Testing safety of heart-lung machine tubes
This study tests two types of tubes used during heart surgery to connect you to a heart-lung machine. It aims to see if they work safely and effectively.
Bari, BAAges 18 years+ - NCT07359534Recruiting
Training recovery with Levagen+ for cyclists and triathletes
This study tests if a supplement called Levagen+ helps trained cyclists and triathletes recover better after hard training. It's looking for healthy active adults who ride at a strong level.
LondonAges 18–50 - NCT07353424Recruiting
Salicornia extract for memory after a small stroke
This study tests whether a polyphenol-rich extract from a salt-tolerant plant called Salicornia can slow memory decline in people who have had a lacunar stroke. It compares the extract to the usual care you would receive.
SevilleAges 40–90 - NCT07356557Recruiting
Medication adherence in inherited metabolic disease patients
This study looks at how well patients with hereditary metabolic diseases take their daily oral medications. It aims to understand if there are challenges with sticking to the treatment plan.
ParisAges 7–20 - NCT07361107RecruitingPhase 1
Immune response study of histotripsy in colorectal cancer
This trial tests how your body's immune system reacts to a treatment called histotripsy for colorectal cancer that has spread to the liver. Histotripsy uses sound waves to break apart tumors, and the study aims to see if this can help your immune system fight the cancer better.
New Hyde Park, New YorkAges 18 years+ - NCT07352930Recruiting
Fluorescence-guided system for breast cancer surgery margins
This trial tests a new imaging system that helps surgeons see if cancer cells remain after breast-conserving surgery. It may reduce the need for a second surgery by giving real-time feedback on the removed tissue.
Guangzhou, GuangdongAges 18 years+ - NCT07359703Recruiting
Aurora test for better embryo selection in ICSI
This study tests a new tool called the Aurora test, which looks at your eggs to help choose the best embryo for transfer. It may help improve success in your first few ICSI cycles.
GhentAges 18–40 - NCT07354893Recruiting
Teaching program after spleen removal
This study tests whether a simple teaching program helps people who had their spleen removed understand their health needs better. It may help you take better care of yourself after surgery and get the right vaccinations.
Rome, LazioAges 18 years+ - NCT07360067Recruiting
Comparing two types of heart pacing for sick sinus syndrome
This study compares two different ways of placing a pacemaker lead to see which one better helps heart function and reduces future heart problems in people with sick sinus syndrome.
Seoul, SeoulAges 19 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,242 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.